VXL.V
Price:
$0.01
Market Cap:
$1.37M
Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company's lead product is ImMucin that has completed a Phase I/II clinical trial for the treatment of multiple myeloma. It is also developing a tuberculosis vaccine/treatment and a coronavirus (COVID-19) vaccine. The company has a collaboration agreement with The Tel Aviv Sourasky Medical Center for the company's research program to develop a potential peptide vaccine against COVID-19; and cooperative research and development agreement with U.S. Army Medical Research Institute of Infectious Diseases for testing CorVax for its abi...[Read more]
Industry
Biotechnology
IPO Date
2010-03-30
Stock Exchange
TSXV
Ticker
VXL.V
According to Vaxil Bio Ltd.’s latest financial reports and current stock price. The company's current ROE is -24.53%. This represents a change of 300.20% compared to the average of -6.13% of the last 4 quarters.
The mean historical ROE of Vaxil Bio Ltd. over the last ten years is -15.42%. The current -24.53% ROE has changed 59.08% with respect to the historical average. Over the past ten years (40 quarters), VXL.V's ROE was at its highest in in the August 2015 quarter at 196.15%. The ROE was at its lowest in in the May 2015 quarter at -1396.34%.
Average
-15.42%
Median
-28.39%
Minimum
-691.92%
Maximum
494.47%
Discovering the peaks and valleys of Vaxil Bio Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 494.47%
Minimum Annual Increase = -9310.61%
Minimum Annual ROE = -691.92%
Year | ROE | Change |
---|---|---|
2023 | -0.03% | -99.94% |
2022 | -51.41% | -11.36% |
2021 | -58.00% | -65.94% |
2020 | -170.27% | -185.21% |
2019 | 199.83% | -183.02% |
2018 | -240.69% | -165.19% |
2017 | 369.20% | -153.36% |
2016 | -691.92% | -239.93% |
2015 | 494.47% | -9310.61% |
2015 | -5.37% | -96.67% |
The current ROE of Vaxil Bio Ltd. (VXL.V) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-36.48%
5-year avg
-15.98%
10-year avg
-15.42%
Vaxil Bio Ltd.’s ROE is greater than Therma Bright Inc. (-196.54%), less than MedMira Inc. (19.53%), less than Lite Access Technologies Inc. (557.63%), greater than Braille Energy Systems Inc. (-203.54%), greater than Datametrex AI Limited (-304.52%),
Company | ROE | Market cap |
---|---|---|
-196.54% | $12.64M | |
19.53% | $64.87M | |
557.63% | $6.87M | |
-203.54% | $7.94M | |
-304.52% | $3.02M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vaxil Bio Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vaxil Bio Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Vaxil Bio Ltd.'s ROE?
How is the ROE calculated for Vaxil Bio Ltd. (VXL.V)?
What is the highest ROE for Vaxil Bio Ltd. (VXL.V)?
What is the 3-year average ROE for Vaxil Bio Ltd. (VXL.V)?
What is the 5-year average ROE for Vaxil Bio Ltd. (VXL.V)?
How does the current ROE for Vaxil Bio Ltd. (VXL.V) compare to its historical average?